Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial ZM Younossi, V Ratziu, R Loomba, M Rinella, QM Anstee, Z Goodman, ... The Lancet 394 (10215), 2184-2196, 2019 | 1051 | 2019 |
Ulipristal acetate versus placebo for fibroid treatment before surgery J Donnez, TF Tatarchuk, P Bouchard, L Puscasiu, NF Zakharenko, ... New England Journal of Medicine 366 (5), 409-420, 2012 | 939 | 2012 |
Ulipristal acetate versus leuprolide acetate for uterine fibroids J Donnez, J Tomaszewski, F Vázquez, P Bouchard, B Lemieszczuk, ... New England Journal of Medicine 366 (5), 421-432, 2012 | 830 | 2012 |
Polyps and cancer of the large bowel: a necropsy study in Liverpool. AR Williams, BA Balasooriya, DW Day Gut 23 (10), 835-842, 1982 | 660 | 1982 |
New concepts for an old problem: the diagnosis of endometrial hyperplasia PA Sanderson, HOD Critchley, ARW Williams, MJ Arends, PTK Saunders Human reproduction update 23 (2), 232-254, 2017 | 407 | 2017 |
The spectrum of endometrial pathology induced by progesterone receptor modulators GL Mutter, C Bergeron, L Deligdisch, A Ferenczy, M Glant, M Merino, ... Modern pathology 21 (5), 591-598, 2008 | 328 | 2008 |
Physiology of the endometrium and regulation of menstruation HOD Critchley, JA Maybin, GM Armstrong, ARW Williams Physiological reviews, 2020 | 320 | 2020 |
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer JMS Bartlett, SP Langdon, BJB Simpson, M Stewart, D Katsaros, ... British journal of cancer 73 (3), 301-306, 1996 | 264 | 1996 |
Mifepristone for treatment of uterine leiomyoma. A prospective randomized placebo controlled trial M Engman, S Granberg, ARW Williams, CX Meng, PGL Lalitkumar, ... Human Reproduction 24 (8), 1870-1879, 2009 | 254 | 2009 |
Expression of the serine protease matriptase and its inhibitor HAI-1 in epithelial ovarian cancer: correlation with clinical outcome and tumor clinicopathological parameters MD Oberst, MD Johnson, RB Dickson, CY Lin, B Singh, M Stewart, ... Clinical cancer research 8 (4), 1101-1107, 2002 | 244 | 2002 |
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor–positive patients JF Smyth, C Gourley, G Walker, MJ MacKean, A Stevenson, ... Clinical Cancer Research 13 (12), 3617-3622, 2007 | 237 | 2007 |
OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer GC Sellar, KP Watt, GJ Rabiasz, EA Stronach, L Li, EP Miller, CE Massie, ... Nature genetics 34 (3), 337-343, 2003 | 236 | 2003 |
Effectiveness of simeprevir plus sofosbuvir, with or without ribavirin, in real-world patients with HCV genotype 1 infection MS Sulkowski, HE Vargas, AM Di Bisceglie, A Kuo, KR Reddy, JK Lim, ... Gastroenterology 150 (2), 419-429, 2016 | 218 | 2016 |
Role of inflammatory mediators in human endometrium during progesterone withdrawal and early pregnancy HOD Critchley, RL Jones, RG Lea, TA Drudy, RW Kelly, ARW Williams, ... The Journal of Clinical Endocrinology & Metabolism 84 (1), 240-248, 1999 | 217 | 1999 |
Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate ARW Williams, C Bergeron, DH Barlow, A Ferenczy International journal of gynecological pathology 31 (6), 556-569, 2012 | 206 | 2012 |
Carcinosarcoma of the ovary: 19 years of prospective data from a single center E Brown, M Stewart, T Rye, A Al‐Nafussi, ARW Williams, M Bradburn, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2004 | 204 | 2004 |
Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24. GM Hampton, LA Penny, RN Baergen, A Larson, C Brewer, S Liao, ... Proceedings of the National Academy of Sciences 91 (15), 6953-6957, 1994 | 188 | 1994 |
Validity of sleep nasendoscopy in the investigation of sleep related breathing disorders S Berry, G Roblin, A Williams, A Watkins, HB Whittet The Laryngoscope 115 (3), 538-540, 2005 | 187 | 2005 |
Immune response to a new hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study JN Zuckerman, C Sabin, MC Fiona, A Williams, AJ Zuckerman Bmj 314 (7077), 329, 1997 | 185 | 1997 |
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas DSP Tan, MBK Lambros, S Rayter, R Natrajan, R Vatcheva, Q Gao, ... Clinical cancer research 15 (7), 2269-2280, 2009 | 181 | 2009 |